Stock Highlights: MediciNova Inc. (NASDAQ:MNOV), Qiwi plc (NASDAQ:QIWI), Johnson Controls Inc. (NYSE:JCI), Novogen Limited (NASDAQ:NVGN), Intuit Inc. (NASDAQ:INTU)

On Thursday shares of MediciNova Inc. (NASDAQ:MNOV) closed at $3.99. Company’s EPS growth for next 5 years is recorded as 20.00%. On 8 May, it was reported MediciNova, Inc., (NASDAQ:MNOV) announced that the National Institute of Neurological Disorders and Stroke (NINDS) notified the company of full enrollment of their ongoing clinical study evaluating ibudilast (MN-166) for the treatment of progressive multiple sclerosis. The trial randomization is aimed to be completed in about 4 to 6 weeks.

Qiwi plc (NASDAQ:QIWI) in last trading activity advanced 15.93% to close at $34.64. Company weekly performance is 24.20% while its quarterly performance stands at 46.10%. Qiwi plc (NASDAQ:QIWI) is -25.14% away from its 52 week high. QIWI plc (NASDAQ: QIWI) entered into an agreement with Otkritie Financial Group (“Otkritie”) to acquire 100% ownership of the Contact money transfer system and the Rapida payment processing system. Under the terms of the agreement, QIWI will issue 5,593,041 class B shares to Otkritie in exchange for all of the outstanding interests in Contact and Rapida.

On last trading day Johnson Controls Inc. (NYSE:JCI) advanced 0.98% to close at $50.45. Its volatility for the week is 1.32% while volatility for the month is 1.80%. JCI’s sales growth for past 5 years was 8.50% and its EPS growth for past 5 years was 41.70%. Johnson Controls Inc. (NYSE:JCI) monthly performance is 0.90%. Johnson Controls (NYSE:JCI) has received a “BBB+” credit rating from analysts at Morningstar. The firm’s “BBB+” rating suggests that the company is a moderate default risk. They also gave their stock a three star rating.

Novogen Limited (NASDAQ:NVGN) has 4.79% insider ownership while its institutional ownership stands at 1.60%. In last trading activity company’s stock closed at $6.34. Novogen Limited (NASDAQ:NVGN) announced that it has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model.

On last trading day Intuit Inc. (NASDAQ:INTU) advanced 1.55% to close at $103.82. Its volatility for the week is 1.50% while volatility for the month is 1.39%. INTU’s sales growth for past 5 years was 7.70% and its EPS growth for past 5 years was 17.00%. Intuit Inc. (NASDAQ:INTU) monthly performance is 5.98%. On 5 May, It’s back in a big way. Intuit Inc. (NASDAQ: INTU) announced the return of Small Business Big Game, culminating in awarding one company an all-expense paid television commercial during professional football’s biggest game on Feb. 7, 2016, at Levi’s Stadium.

Worth Watching Stocks: MediciNova Inc. (NASDAQ:MNOV), Dipexium Pharmaceuticals (NASDAQ:DPRX), ARM Holdings plc (NASDAQ:ARMH), Daktronics Inc. (NASDAQ:DAKT), Heartware International Inc. (NASDAQ:HTWR)

On Friday shares of MediciNova Inc. (NASDAQ:MNOV) closed at $4.00. Company’s EPS growth for next 5 years is recorded as 20.00%. On May 8, MediciNova, Inc., (NASDAQ:MNOV) announced that the National Institute of Neurological Disorders and Stroke (NINDS) notified the company of full enrollment of their ongoing clinical study evaluating ibudilast (MN-166) for the treatment of progressive multiple sclerosis. The trial randomization is aimed to be completed in about 4 to 6 weeks.

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) in last trading activity advanced 7.86% to close at $12.62. Company weekly performance is 5.61% while its quarterly performance stands at 13.18%. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) is -16.64% away from its 52 week high. Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) will release its financial results for the quarter ended March 31, 2015, on Thursday, May 14, 2015 at 7:30 a.m. ET. The announcement will be followed by a conference call at 8:30 a.m. ET during which Dipexium management will discuss these results, recent developments and answer questions.

On Friday shares of ARM Holdings plc (NASDAQ:ARMH) closed at $52.85. Company’s sales growth for last 5 years was 21.10% and EPS growth for next 5 years is recorded as 18.40%. ARM Holdings plc (NASDAQ:ARMH)‘s stock had its “outperform” rating reissued by equities researchers at BNP Paribas in a research report issued on Thursday. They currently have a GBX 1,300 ($19.70) price target on the stock. BNP Paribas’ price target points to a potential upside of 14.54% from the stock’s previous close.

Daktronics Inc. (NASDAQ:DAKT) has 8.10% insider ownership while its institutional ownership stands at 48.00%. In last trading activity company’s stock closed at $10.69. On May 8, Daktronics Inc. (NASDAQ:DAKT) announced the integration of Fliphound into its Visiconn management software to enable direct access of the buying and bidding platform offered by Fliphound for Daktronics display owners. The deal will allow Fliphound, an established online marketplace for purchasing digital billboard advertising, to enable seamless and automatic configuration of its platform for Daktronics display owners, thus facilitating the online selling of its digital inventory.

On last trading day Heartware International Inc. (NASDAQ:HTWR) decreased -0.31% to close at $73.25. Its volatility for the week is 3.35% while volatility for the month is 4.02%. HTWR’s sales growth for past 5 years was 63.00% and its EPS growth for past 5 years was 11.90%. Heartware International Inc. (NASDAQ:HTWR) monthly performance is -19.43%. On May 7, HeartWare International Inc. (NASDAQ:HTWR) announced that it has entered into privately-negotiated exchange and subscription agreements with a limited number of holders of the Company’s outstanding 3.50% Convertible Senior Notes due 2017 (“2017 Notes”). The 2021 Notes will mature on December 15 2021 and will bear interest at a rate of 1.75% per year payable semiannually in arrears on June 15 and December 15 of each year beginning on December 15 2015.

Investors Alert: Hologic Inc. (NASDAQ:HOLX), EMC Corporation (NYSE:EMC), MediciNova Inc. (NASDAQ:MNOV), Cameron International Corporation (NYSE:CAM), Vermillion (NASDAQ:VRML)

On Thursday shares of Hologic Inc. (NASDAQ:HOLX) closed at $32.82. Company’s sales growth for last 5 years was 9.10% and EPS growth for next 5 years is recorded as 7.90%. Hologic Inc. (NASDAQ:HOLX) commented on an important cervical cancer screening study published on-line this week in Cancer Cytopathology, a peer-reviewed journal of the American Cancer Society. The study, by researchers at Quest Diagnostics and the University of Pittsburgh Medical Center, supports current consensus guidelines for cervical cancer screening, which recommend that women 30-65 years of age be co-tested with both Pap and human papillomavirus (HPV) tests.

EMC Corporation (NYSE:EMC) in last trading activity moved down -0.65% to close at $26.05. Company weekly performance is 0.39% while its quarterly performance stands at -7.00%. EMC Corporation (NYSE:EMC) is -15.04% away from its 52 week high. EMC Corporation (NYSE:EMC) will publish its first-quarter 2015 financial results on April 22, 2015 at approximately 7:00 a.m. ET. EMC will also issue an advisory news release on April 22, 2015 announcing availability of the results via the EMC Investor Relations.

On last trading day MediciNova Inc. (NASDAQ:MNOV) advanced 41.31% to close at $4.96. Its volatility for the week is 6.58% while volatility for the month is 4.84%. MNOV’s EPS growth for past 5 years was 25.70%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is 51.68%. MediciNova, Inc.( NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), announced that it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for MN-001 (tipelukast) for the treatment of patients with nonalcoholic steatohepatitis (NASH) with fibrosis. Fast Track is a process designed to facilitate the development and expedite the review of drugs that are intended to treat serious or life-threatening diseases and demonstrate the potential to address unmet medical needs for such diseases.

Cameron International Corporation (NYSE:CAM) has 0.40% insider ownership while its institutional ownership stands at 93.50%. In last trading activity company’s stock closed at $50.55. Cameron International (NYSE:CAM) had its target price boosted by Susquehanna from $50.00 to $57.00 in a report issued on Wednesday. They currently have a positive rating on the stock.

On last trading day Vermillion, Inc. (NASDAQ:VRML) advanced 2.22% to close at $1.84. Its volatility for the week is 4.49% while volatility for the month is 8.20%. VRML’s EPS growth for past 5 years was 30.70%. Vermillion, Inc. (NASDAQ:VRML) monthly performance is 3.95%. On April 14, Vermillion, Inc. (NASDAQ:VRML) announced the initiation of a strategic partnership with Kaiser Permanente’s Southern California Permanente Medical Group (“SCPMG”) in order to enhance the diagnosis and treatment of ovarian cancer. The collaboration further advances Vermillion’s landmark alliances with health care organizations to develop breakthrough solutions for the improvement of quality and evidence-based care for women.

Hot Alert: United States Steel Corp. (NYSE:X), Groupon (NASDAQ:GRPN), General Electric Company (NYSE:GE), SunEdison (NYSE:SUNE), MediciNova Inc. (NASDAQ:MNOV)

On Wednesday shares of United States Steel Corp. (NYSE:X) closed at $24.81. Company’s sales growth for last 5 years was 9.60% and EPS growth for next 5 years is recorded as -1.31%. United States Steel Corporation (NYSE:X) announced that it will consolidate its North American Flat Rolled operations and temporarily idle its Granite City Works operations in Granite City in Illinois. As part of the consolidation, 2,080 employees at Granite City Works are being issued notices under the Worker Adjustment and Retraining Notification Act.

Groupon, Inc. (NASDAQ:GRPN) in last trading activity increased 2.38% to close at $7.74. Company quarterly performance stands at -2.64%. Groupon, Inc. (NASDAQ:GRPN) is -8.19% away from its 52 week high. Shares of Groupon Inc. (NASDAQ:GRPN) closed up 2.4% on Thursday after an analyst upgraded the stock and said the company is seeing repeat buyers despite concerns that interest in the platform would eventually wane.

On last trading day General Electric Company (NYSE:GE) moved down -1.42% to close at $24.91. Its volatility for the week is 1.19% while volatility for the month is 1.46%. GE’s sales growth for past 5 years was -0.80% and its EPS growth for past 5 years was 8.80%. General Electric Company (NYSE:GE) monthly performance is -1.89%. General Electric Company (NYSE:GE) increased planned job cuts in its Lufkin oilfield equipment unit to 575, as it grapples with pressure on the unit from the drop in oil prices.

On Wednesday shares of SunEdison, Inc. (NYSE:SUNE) closed at $23.82. Company’s sales growth for last 5 years was 16.40% and EPS growth for next 5 years is recorded as 1.58%. SunEdison, Inc. (NYSE: SUNE) announced that it plans to purchase up to 1,000 vanadium flow batteries (over 100 megawatt hours) from Imergy Power Systems, a leader in advanced energy storage solutions.

On last trading day MediciNova Inc. (NASDAQ:MNOV) moved down -5.48% to close at $3.28. Its volatility for the week is 4.02% while volatility for the month is 5.12%. MNOV’s EPS growth for past 5 years was 25.70%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is -7.61%.Biopharmaceutical company MediciNova, Inc. announced that an abstract on the company’s ongoing clinical trial of MN-166 (ibudilast) to address amyotrophic lateral sclerosis (ALS) has been accepted for presentation at the American Academy of Neurology (AAN) 67th Annual Meeting, which will take place on April 18 to 25, 2015 in Washington, DC.

Keep Eyes on: Tesla Motors Inc (NASDAQ:TSLA), County Bancorp (NASDAQ:ICBK), The Men’s Wearhouse (NYSE:MW), Dealertrack Technologies (NASDAQ:TRAK), MediciNova (NASDAQ:MNOV)

Tesla Motors Inc (NASDAQ:TSLA) Chief Executive Elon Musk said the company’s market capitalization could equal that of Apple Inc.’s in 10 years. Apple recently became the first company to top $700 billion in market cap. Tesla’s current market value is roughly $27 billion or less than 4% of Apple’s. On Wednesday shares of Tesla Motors Inc (NASDAQ:TSLA) closed at $211.97. Company’s sales growth for last 5 years was 167.50%.

Newly public County Bancorp Inc. (NASDAQ:ICBK) said Tuesday earnings rose 17.1% on strong loan growth in its final year as a private company. The Manitowoc parent company of Investors Community Bank said net income rose to $8.21 million, or $1.69 a share, in 2014 from $7.01 million, or $1.45, in 2013. County Bancorp, Inc. (NASDAQ:ICBK) in last trading activity advanced 7.37% to close at $20.55. Company weekly performance is 8.04%. County Bancorp, Inc. (NASDAQ:ICBK) is 0.74% away from its 52 week high.

It was reported on 27 January 2015, that The Men’s Wearhouse, Inc. (NYSE:MW) announced that its Board of Directors declared a quarterly cash dividend of $0.18 per share on the Company’s common stock, payable on March 27, 2015 to shareholders of record at the close of business on March 17, 2015. On last trading day The Men’s Wearhouse, Inc. (NYSE:MW) advanced 0.53% to close at $48.93. Its volatility for the week is 1.77% while volatility for the month is 2.78%. MW’s sales growth for past 5 years was 4.60% and its EPS growth for past 5 years was 8.50%. The Men’s Wearhouse, Inc. (NYSE:MW) monthly performance is 10.63%.

Dealertrack Technologies, Inc. (Nasdaq:TRAK), on 28 January 2015, announced that it will release its fourth quarter and full year 2014 financial results after the market closes on Monday, February 23, 2015. A conference call will be hosted by Mark F. O’Neil, chairman and chief executive officer, and Eric D. Jacobs, chief financial and administrative officer, that evening beginning at 5:00 pm (ET). Dealertrack Technologies, Inc. (NASDAQ:TRAK) has 1.30% insider ownership while its institutional ownership stands at 92.40%. In last trading activity company’s stock closed at $40.88.

MediciNova Inc. (NASDAQ:MNOV), on 3 February 2015, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of NASH (nonalcoholic steatohepatitis). On last trading day MediciNova Inc. (NASDAQ:MNOV) decreased -0.48% to close at $4.18. Its volatility for the week is 5.33% while volatility for the month is 5.40%. MNOV’s EPS growth for past 5 years was 36.40%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is 27.44%.

Ever Green Stocks: Brocade Communications Systems (NASDAQ:BRCD), Epizyme (NASDAQ:EPZM), Unum Group (NYSE:UNM), TiVo Inc. (NASDAQ:TIVO), MediciNova Inc. (NASDAQ:MNOV)

Brocade Communications Systems, Inc. (NASDAQ:BRCD) was upgraded by stock analysts at Citigroup Inc. from a “sell” rating to a “buy” rating in a report issued on Thursday. On Tuesday shares of Brocade Communications Systems, Inc. (NASDAQ:BRCD) closed at $11.94. Company’s sales growth for last 5 years was 2.50% and EPS growth for next 5 years is recorded as 8.33%.

Epizyme, Inc. (NASDAQ:EPZM) announced its participation in RBC Capital Markets 2015 Global Healthcare Conference at the New York Palace Hotel in New York on Tuesday February 24 at 10:30 a.m. EST. Epizyme, Inc. (NASDAQ:EPZM) in last trading activity advanced 8.00% to close at $19.97. Company weekly performance is 9.97% while its quarterly performance stands at -15.92%. Epizyme, Inc. (NASDAQ:EPZM) is -51.27% away from its 52 week high.

On 27 January, Unum Group (NYSE:UNM) reported a net loss of $279.1 million ($1.11 per common share) for the fourth quarter of 2014, compared to net income of $221.2 million ($0.84 per common share) for the fourth quarter of 2013. On last trading day Unum Group (NYSE:UNM) advanced 0.39% to close at $33.56. Its volatility for the week is 2.18% while volatility for the month is 2.33%. UNM’s sales growth for past 5 years was 0.80% and its EPS growth for past 5 years was -8.80%. Unum Group (NYSE:UNM) monthly performance is 2.19%.

On 27 January, TiVo Inc. (NASDAQ:TIVO) has entered into a partnership with Ness Software Engineering Services (SES) to help build TiVo’s European development centre. TiVo Inc. (NASDAQ:TIVO) has 3.20% insider ownership while its institutional ownership stands at 96.90%. In last trading activity company’s stock closed at $10.77.

On 28 January, MediciNova Inc. (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange announced that the IND (Investigational New Drug) Application for MN-001 (tipelukast) for the treatment of NASH (nonalcoholic steatohepatitis) has been accepted and is now open with the FDA (U.S. Food and Drug Administration). Importantly, due to safety data from previous clinical studies of MN-001, FDA has agreed that MediciNova may proceed with a Phase 2 study as the first clinical study of MN-001 in NASH. On last trading day MediciNova Inc. (NASDAQ:MNOV) advanced 5.00% to close at $4.20. Its volatility for the week is 5.73% while volatility for the month is 5.64%. MNOV’s EPS growth for past 5 years was 36.40%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is 30.43%.

Stocks to Keep Eyes On: Criteo SA (NASDAQ:CRTO), Triangle Petroleum Corporation (NYSEMKT: TPLM), Newpark Resources Inc. (NYSE:NR), MediciNova Inc. (NASDAQ:MNOV)

Criteo SA (NASDAQ:CRTO) will announce its financial results for the fourth quarter and fiscal year ended December 31, 2014 on Wednesday, February 18, 2015 before market open. On Tuesday shares of Criteo SA (NASDAQ:CRTO) closed at $40.86. Company’s EPS growth for next 5 years is recorded as 46.50%.

Triangle Petroleum Corporation (NYSEMKT: TPLM) had its price target lowered by Topeka Capital Markets from $7.00 to $4.00 in a research report sent to investors on Friday morning. The firm currently has a hold rating on the stock. Triangle Petroleum Corporation (NYSEMKT: TPLM) in last trading activity moved down -7.64% to close at $5.20. Company weekly performance is -7.14% while its quarterly performance stands at -29.16%. Triangle Petroleum Corporation (NYSEMKT: TPLM) is -58.33% away from its 52 week high.

Newpark Resources Inc. (NYSE:NR) announced that it will release its fourth quarter and year-end 2014 results on Thursday, February 12, 2015 after the market closes. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, on Friday, February 13, 2015 at 10:00 a.m. Eastern / 9:00 a.m. Central. On last trading day Newpark Resources Inc. (NYSE:NR) moved down -2.66% to close at $9.15. Its volatility for the week is 3.88% while volatility for the month is 4.20%. NR’s sales growth for past 5 years was 4.00% and its EPS growth for past 5 years was 4.90%. Newpark Resources Inc. (NYSE:NR) monthly performance is 3.04%.

On 28 January, MediciNova Inc. (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange announced that the IND (Investigational New Drug) Application for MN-001 (tipelukast) for the treatment of NASH (nonalcoholic steatohepatitis) has been accepted and is now open with the FDA (U.S. Food and Drug Administration). Importantly, due to safety data from previous clinical studies of MN-001, FDA has agreed that MediciNova may proceed with a Phase 2 study as the first clinical study of MN-001 in NASH. On last trading day MediciNova Inc. (NASDAQ:MNOV) advanced 5.00% to close at $4.20. Its volatility for the week is 5.73% while volatility for the month is 5.64%. MNOV’s EPS growth for past 5 years was 36.40%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is 30.43%.

Biotechnology Top Losers: Regulus Therapeutics Inc. (NASDAQ:RGLS), Genetic Technologies Limited (NASDAQ:GENE), NanoString Technologies (NASDAQ:NSTG), MediciNova Inc. (NASDAQ:MNOV), Medgenics (NYSEMKT:MDGN)

Regulus Therapeutics Inc. (NASDAQ:RGLS), announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 (“miR-122”), for the treatment of hepatitis C virus infection (“HCV”). On Monday shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) closed at $15.64. Company’s EPS growth for next 5 years is recorded as 39.60%.

On 28 January, Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus to their at-risk patients in a systematic broad Genetic Technologies Ltd. (NASDAQ: GENE) fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar year 2015. Genetic Technologies Limited (NASDAQ:GENE) in last trading activity moved down -6.84% to close at $3.68. Company weekly performance is 42.08% while its quarterly performance stands at 67.27%. Genetic Technologies Limited (NASDAQ:GENE) is -69.46% away from its 52 week high.

NanoString Technologies, Inc. (NASDAQ:NSTG), announced that its management is scheduled to present at the 2015 Leerink Global Healthcare Conference in New York. Brad Gray, President and Chief Executive Officer, is scheduled to present on Wednesday, February 11, 2015 at 8:25am ET.On last trading day NanoString Technologies, Inc. (NASDAQ:NSTG) moved down -5.48% to close at $12.77. Its volatility for the week is 5.26% while volatility for the month is 5.46%. NSTG’s sales growth for past 5 years was 81.40% and its EPS growth for past 5 years was 33.60%. NanoString Technologies, Inc. (NASDAQ:NSTG) monthly performance is -2.44%.

On 3 February, MediciNova, Inc., (NASDAQ:MNOV) announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of NASH (nonalcoholic steatohepatitis). MediciNova Inc. (NASDAQ:MNOV) has 0.30% insider ownership while its institutional ownership stands at 9.80%. In last trading activity company’s stock closed at $4.00.

Medgenics, Inc. (NYSEMKT:MDGN) will host a conference call and live audio webcast on Friday, February 13, 2015 at 8:30 a.m. ET to discuss fourth quarter and full year 2014 financial results. On last trading day Medgenics, Inc. (NYSEMKT:MDGN) moved down -5.66% to close at $7.00. Its volatility for the week is 6.81% while volatility for the month is 8.23%. MDGN’s EPS growth for past 5 years was 10.00%. Medgenics, Inc. (NYSEMKT:MDGN) monthly performance is 10.41%.

Stocks Gaining Momentum: The Walt Disney Company (NYSE:DIS), Accenture plc (NYSE:ACN), StarTek (NYSE:SRT), Maxwell Technologies (NASDAQ:MXWL), Envision Healthcare Holdings (NYSE:EVHC)

The Walt Disney Company (NYSE:DIS) named Thomas Staggs as chief operating officer, an indication that the company might be setting up a successor for CEO Bob Iger. On Thursday shares of The Walt Disney Company (NYSE:DIS) closed at $102.64. Company’s sales growth for last 5 years was 6.20% and EPS growth for next 5 years is recorded as 15.77%.

Accenture (NYSE:ACN) was named by KLAS Research as the category leader in consulting services for transitioning to ICD-10 diagnostic codes and standards. The 2014 Best in KLAS Awards rated Accenture as the top-performing vendor, with a score of 92.6, based on an industry ranking of 11 professional services firms. Accenture plc (NYSE:ACN) in last trading activity moved up 1.29% to close at $88.47. Company weekly performance is 3.30% while its quarterly performance stands at 9.02%. Accenture plc (NYSE:ACN) is -3.77% away from its 52 week high.

Maxwell Technologies (NASDAQ:MXWL) reported Q4 EPS of $0.02, $0.02 better than the analyst estimate of $0.00. Revenue for the quarter came in at $52.9 million versus the consensus estimate of $50.5 million.On last trading day Maxwell Technologies, Inc. (NASDAQ:MXWL) increased 4.83% to close at $8.25. Its volatility for the week is 5.24% while volatility for the month is 5.31%. MXWL’s sales growth for past 5 years was 19.20% and its EPS growth for past 5 years was 18.20%. Maxwell Technologies, Inc. (NASDAQ:MXWL) monthly performance is -4.29%.

MediciNova, Inc., (NASDAQ:MNOV) on 3 February announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of NASH (nonalcoholic steatohepatitis). MediciNova Inc. (NASDAQ:MNOV) has 0.30% insider ownership while its institutional ownership stands at 9.80%. In last trading activity company’s stock closed at $3.89.

Envision Healthcare Holdings, Inc. (NYSE:EVHC) plans to release its fourth quarter and full-year 2014 operating results Thursday, February 26, 2015, after market close, with a conference call to follow at 5:00 p.m. Eastern Time.On last trading day Envision Healthcare Holdings, Inc. (NYSE:EVHC) moved up 3.08% to close at $35.79. Its volatility for the week is 2.59% while volatility for the month is 2.67%. EVHC’s sales growth for past 5 years was 9.10% and its EPS growth for past 5 years was -28.20%. Envision Healthcare Holdings, Inc. (NYSE:EVHC) monthly performance is 4.34%.

Stocks to Watch: 3D Systems Corporation (NYSE:DDD), The Procter & Gamble Company (NYSE:PG), Pure Cycle Corporation (NASDAQ:PCYO), Reading International (NASDAQ:RDI), MediciNova (NASDAQ:MNOV)

3D Systems Corporation (NYSE:DDD) announced that it plans to present at the Stifel 2015 Technology, Internet & Media Conference at The Westin St. Francis in San Francisco, CA on Monday, February 9, 2015 at 11:30 AM PT. On Tuesday shares of 3D Systems Corporation (NYSE:DDD) closed at $28.62. Company’s sales growth for last 5 years was 29.90% and EPS growth for next 5 years is recorded as 21.33%.

The Procter & Gamble Company (NYSE:PG) on 27 January reported second quarter fiscal year 2015 core earnings per share of $1.06 versus $1.15 the prior year. On a currency-neutral basis, core earnings per share increased six percent. Diluted net earnings per share were $0.82, including non-core items which reduced diluted EPS by $0.24 per share. Organic sales grew two percent for the quarter. The Procter & Gamble Company (NYSE:PG) in last trading activity moved up 0.98% to close at $85.95. Company weekly performance is -0.62% while its quarterly performance stands at -0.81%. The Procter & Gamble Company (NYSE:PG) is -7.80% away from its 52 week high.

Pure Cycle Corporation (NASDAQ: PCYO) announces that the Company and High Plains A&M, LLC (“HP”) have reached a comprehensive settlement of all outstanding litigation. On last trading day Pure Cycle Corporation (NASDAQ:PCYO) decreased -0.48% to close at $4.18. Its volatility for the week is 5.09% while volatility for the month is 4.85%. PCYO’s sales growth for past 5 years was 59.50% and its EPS growth for past 5 years was 48.60%. Pure Cycle Corporation (NASDAQ:PCYO) monthly performance is 5.82%.

Reading International (NASDAQ:RDI) Director Douglas James Mceachern bought 6,000 shares of the stock on the open market in a transaction dated Wednesday, January 21st. The shares were purchased at an average cost of $12.01 per share, with a total value of $72,060.00. Reading International, Inc. (NASDAQ:RDI) has 4.90% insider ownership while its institutional ownership stands at 25.20%. In last trading activity company’s stock closed at $12.09.

MediciNova, Inc., (NASDAQ:MNOV) announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-001 (tipelukast) and MN-002 (a major metabolite of MN-001) for the treatment of NASH (nonalcoholic steatohepatitis). On last trading day MediciNova Inc. (NASDAQ:MNOV) moved down -1.54% to close at $3.84. Its volatility for the week is 7.50% while volatility for the month is 6.83%. MNOV’s EPS growth for past 5 years was 36.40%. MediciNova Inc. (NASDAQ:MNOV) monthly performance is 16.36%.